• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项观察性试点研究,采用数据关怀干预策略,以促进失访的HIV/HCV合并感染患者重新接受丙肝治疗并实现治愈。

Observational pilot using a Data to Care intervention strategy to promote HCV re-engagement and cure for persons with HIV/HCV co-infection who are out of care.

作者信息

Wegener Maximilian, Gosselin Deborah, Brooks Ralph, Speers Suzanne, Villanueva Merceditas

机构信息

Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06510, USA.

Connecticut Department of Public Health, 410 Capitol Ave, Hartford, CT, 06134, USA.

出版信息

BMC Health Serv Res. 2025 Jan 25;25(1):140. doi: 10.1186/s12913-025-12307-6.

DOI:10.1186/s12913-025-12307-6
PMID:39856760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11763122/
Abstract

BACKGROUND

With Direct Acting Antivirals for Hepatitis C virus (HCV), cure is possible in > 95% including those with HIV/HCV co-infection. Achieving strategic targets for cure requires addressing barriers including suboptimal care engagement. We adapted Data to Care (D2C), a public health strategy designed to identify and link persons out of care (OOC) for HIV, for persons with HIV/HCV co-infection untreated for HCV.

METHODS

In partnership with Connecticut Department of Public Health (DPH), persons OOC for HIV (defined as no HIV surveillance laboratory tests from 10/1/2018-10/1/2019) were matched to a list of persons co-infected with HIV/HCV (through 12/31/2019). We used a three-phase follow-up approach (pre-work, case conferencing, and Disease Intervention Specialist (DIS) follow-up) to track outreach outcomes and re-engagement/HCV cure success.

RESULTS

There were 90 HIV/HCV co-infected persons who were OOC for HIV. The pre-work and case conferencing phases determined that 33 (36.7%) had previous HCV cure or were in treatment. There were 41 eligible for DIS-follow-up of which 21 (51%) were successfully contacted and 7 (33%) successfully re-engaged (kept appointment with HCV provider). No new HCV treatment initiations were recorded.

CONCLUSIONS

Using a D2C approach, we identified and conducted outreach to persons who were OOC for HIV to promote HCV treatment. This approach resulted in intensive data clean-up and outreach efforts which produced modest re-engagement and no HCV treatment initiations. Future studies should develop alternative and complementary interventions to promote effective re-engagement and HCV treatment.

摘要

背景

使用丙型肝炎病毒(HCV)直接抗病毒药物,超过95%的患者(包括HIV/HCV合并感染患者)有可能治愈。实现治愈的战略目标需要克服包括护理参与度欠佳在内的障碍。我们对“以数据促护理”(D2C)进行了调整,这是一项公共卫生策略,旨在识别未接受护理的HIV感染者并将其与护理机构联系起来,现应用于未接受HCV治疗的HIV/HCV合并感染患者。

方法

与康涅狄格州公共卫生部门(DPH)合作,将未接受护理的HIV感染者(定义为在2018年10月1日至2019年10月1日期间未进行HIV监测实验室检测)与HIV/HCV合并感染患者名单(截至2019年12月31日)进行匹配。我们采用三阶段随访方法(工作前、病例会诊和疾病干预专家(DIS)随访)来跟踪外展服务结果以及重新参与护理/HCV治愈情况。

结果

有90名HIV/HCV合并感染患者未接受HIV护理。工作前和病例会诊阶段确定,33名患者(36.7%)既往已治愈HCV或正在接受治疗。有41名患者符合DIS随访条件,其中21名(51%)成功联系上,7名(33%)成功重新参与护理(与HCV治疗提供者预约就诊)。未记录到新开始HCV治疗的病例。

结论

采用D2C方法,我们识别并对未接受HIV护理的患者进行了外展服务,以促进HCV治疗。这种方法导致了密集的数据清理和外展工作,产生了一定程度的重新参与护理情况,但没有新开始HCV治疗的病例。未来的研究应开发替代和补充性干预措施,以促进有效的重新参与护理和HCV治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec4/11763122/ade2d787e1d5/12913_2025_12307_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec4/11763122/6499e3abc317/12913_2025_12307_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec4/11763122/ade2d787e1d5/12913_2025_12307_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec4/11763122/6499e3abc317/12913_2025_12307_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec4/11763122/ade2d787e1d5/12913_2025_12307_Fig2_HTML.jpg

相似文献

1
Observational pilot using a Data to Care intervention strategy to promote HCV re-engagement and cure for persons with HIV/HCV co-infection who are out of care.一项观察性试点研究,采用数据关怀干预策略,以促进失访的HIV/HCV合并感染患者重新接受丙肝治疗并实现治愈。
BMC Health Serv Res. 2025 Jan 25;25(1):140. doi: 10.1186/s12913-025-12307-6.
2
Creating a Longitudinal HCV Care Cascade for Persons With HIV/HCV Coinfection in Selected HIV Clinics Using Data to Care Methods.利用数据关怀方法,为选定的艾滋病诊所中合并感染艾滋病毒/丙型肝炎病毒的患者建立纵向丙型肝炎病毒关怀流程。
Health Promot Pract. 2023 Sep;24(5):1039-1049. doi: 10.1177/15248399231169792. Epub 2023 Jul 13.
3
Characterizing Persons With HIV/HCV Coinfection Who Remain Untreated for Hepatitis C at Four HIV Clinics in Connecticut (CT): Role of Multiple Overlapping Barriers at the Individual and Clinic System Levels.描述在康涅狄格州(CT)的四家 HIV 诊所中,仍未接受丙型肝炎治疗的 HIV/HCV 合并感染患者的特征:个体和诊所系统层面上多种重叠障碍的作用。
Health Promot Pract. 2023 Sep;24(5):1029-1038. doi: 10.1177/15248399231169793. Epub 2023 Jul 13.
4
Implementing a Surveillance-Based Approach to Create a Statewide Viral Clearance Cascade for Hepatitis C Among People With HIV and HCV Coinfection in Connecticut.在康涅狄格州实施基于监测的方法,为艾滋病毒和丙型肝炎病毒合并感染人群建立全州范围的丙型肝炎病毒清除级联。
Public Health Rep. 2024 Mar-Apr;139(2):208-217. doi: 10.1177/00333549231172173. Epub 2023 May 26.
5
Advancing data to care strategies for persons with HIV using an innovative reconciliation process.利用创新的协调流程推进艾滋病毒感染者的数据关爱策略。
PLoS One. 2022 May 5;17(5):e0267903. doi: 10.1371/journal.pone.0267903. eCollection 2022.
6
Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.既往监禁经历会影响加拿大 HIV/HCV 共感染患者获得 HCV 治疗的机会。
J Int AIDS Soc. 2018 Nov;21(11):e25197. doi: 10.1002/jia2.25197.
7
Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.加拿大艾滋病毒与丙型肝炎合并感染人群中直接作用抗病毒药物使用情况的差异。
J Int AIDS Soc. 2017 Nov;20(3). doi: 10.1002/jia2.25013.
8
Nurse case management to improve the hepatitis C care continuum in HIV co-infection: Results of a randomized controlled trial.护士病例管理改善 HIV 合并感染丙型肝炎护理连续体:一项随机对照试验的结果。
J Viral Hepat. 2020 Apr;27(4):376-386. doi: 10.1111/jvh.13241. Epub 2019 Dec 9.
9
Management of acute and chronic HCV infection in persons with HIV coinfection.HIV 合并感染者的急性和慢性 HCV 感染的管理。
J Hepatol. 2014 Nov;61(1 Suppl):S108-19. doi: 10.1016/j.jhep.2014.08.006. Epub 2014 Nov 3.
10
HCV-HIV co-infection in people who inject drugs: Barriers to treatment and cure of HCV infection in the era of DAAs, a prospective study in Athens, Greece.在注射毒品者中合并感染 HCV 和 HIV:在 DAA 时代治疗和治愈 HCV 感染的障碍,希腊雅典的一项前瞻性研究。
HIV Med. 2024 Oct;25(10):1135-1144. doi: 10.1111/hiv.13681. Epub 2024 Jun 20.

引用本文的文献

1
Hepatitis C Virus (HCV) Clearance Cascade for Persons With Human Immunodeficiency Virus (HIV)/HCV Coinfection Using Health Department Surveillance Data Among 7 US Jurisdictions Highlights the Role of HIV Care Engagement.利用美国7个司法管辖区的卫生部门监测数据,对人类免疫缺陷病毒(HIV)/丙型肝炎病毒(HCV)合并感染患者的丙型肝炎病毒清除级联反应突出了HIV治疗参与的作用。
Open Forum Infect Dis. 2025 Aug 7;12(8):ofaf412. doi: 10.1093/ofid/ofaf412. eCollection 2025 Aug.
2
Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People with HIV in Project CoRECT: A Mixed Methods Study.疾病干预专家在项目CoRECT中重新联系失访艾滋病毒感染者方面的实地经验:一项混合方法研究
AIDS Behav. 2025 Apr 10. doi: 10.1007/s10461-025-04707-w.

本文引用的文献

1
Characterizing Persons With HIV/HCV Coinfection Who Remain Untreated for Hepatitis C at Four HIV Clinics in Connecticut (CT): Role of Multiple Overlapping Barriers at the Individual and Clinic System Levels.描述在康涅狄格州(CT)的四家 HIV 诊所中,仍未接受丙型肝炎治疗的 HIV/HCV 合并感染患者的特征:个体和诊所系统层面上多种重叠障碍的作用。
Health Promot Pract. 2023 Sep;24(5):1029-1038. doi: 10.1177/15248399231169793. Epub 2023 Jul 13.
2
Creating a Longitudinal HCV Care Cascade for Persons With HIV/HCV Coinfection in Selected HIV Clinics Using Data to Care Methods.利用数据关怀方法,为选定的艾滋病诊所中合并感染艾滋病毒/丙型肝炎病毒的患者建立纵向丙型肝炎病毒关怀流程。
Health Promot Pract. 2023 Sep;24(5):1039-1049. doi: 10.1177/15248399231169792. Epub 2023 Jul 13.
3
Implementing a Surveillance-Based Approach to Create a Statewide Viral Clearance Cascade for Hepatitis C Among People With HIV and HCV Coinfection in Connecticut.在康涅狄格州实施基于监测的方法,为艾滋病毒和丙型肝炎病毒合并感染人群建立全州范围的丙型肝炎病毒清除级联。
Public Health Rep. 2024 Mar-Apr;139(2):208-217. doi: 10.1177/00333549231172173. Epub 2023 May 26.
4
Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World Examples.丙型肝炎病毒感染的快速治疗启动:潜在益处、当前局限性及实际案例
Gastroenterol Hepatol (N Y). 2022 Nov;18(11):628-638.
5
The Cooperative Re-Engagement Controlled trial (CoRECT): A randomised trial to assess a collaborative data to care model to improve HIV care continuum outcomes.合作再参与对照试验(CoRECT):一项随机试验,旨在评估一种协作式数据到护理模式,以改善艾滋病毒护理连续结果。
Lancet Reg Health Am. 2021 Aug 28;3:100057. doi: 10.1016/j.lana.2021.100057. eCollection 2021 Nov.
6
Rapid Treatment Initiation for Hepatitis C in Young People Who Inject Drugs: The Seek, Test, and Rapid Treatment Randomized Trial.为注射毒品的年轻人快速启动丙型肝炎治疗:寻求、检测和快速治疗随机试验
Open Forum Infect Dis. 2022 May 7;9(7):ofac225. doi: 10.1093/ofid/ofac225. eCollection 2022 Jul.
7
Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs): A Qualitative Analysis with Persons with HIV/HCV Co-infection Who Delay or Refuse Treatment.直接作用抗病毒药物(DAA)治疗丙型肝炎病毒(HCV)的认知:对延迟或拒绝治疗的 HIV/HCV 合并感染患者进行定性分析。
AIDS Behav. 2023 Jan;27(1):119-133. doi: 10.1007/s10461-022-03749-8. Epub 2022 Jul 1.
8
Advancing data to care strategies for persons with HIV using an innovative reconciliation process.利用创新的协调流程推进艾滋病毒感染者的数据关爱策略。
PLoS One. 2022 May 5;17(5):e0267903. doi: 10.1371/journal.pone.0267903. eCollection 2022.
9
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.一种最小监测方法治疗丙型肝炎病毒感染(ACTG A5360 [MINMON]):一项 4 期、开放标签、单臂试验。
Lancet Gastroenterol Hepatol. 2022 Apr;7(4):307-317. doi: 10.1016/S2468-1253(21)00397-6. Epub 2022 Jan 10.
10
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.在 COVID-19 应对期间,在注射毒品者的注射器服务项目中治疗丙型肝炎病毒:远程医疗、阿片类药物使用障碍治疗药物和对患者低要求的潜在作用。
Int J Drug Policy. 2022 Mar;101:103570. doi: 10.1016/j.drugpo.2021.103570. Epub 2021 Dec 20.